Abstract
Chlamydia is the most commonly diagnosed bacterial sexually transmitted infection in the developed world, with diagnosis rates continuing to increase each year. As chlamydia is largely asymptomatic, screening and treatment is the main way to detect cases and reduce transmission. Recent advances in self-collected specimens and laboratory tests has made chlamydia screening easier to implement as well as possible in nonclinical settings. This review will discuss new approaches to specimen collection and how these have expanded opportunities for reaching target populations for chlamydia screening. Furthermore, it will discuss how advanced molecular microbiological methods can be used with self-collected specimens to further our knowledge of the epidemiology of chlamydia and the dynamics of transmission.
Original language | English |
---|---|
Pages (from-to) | 367-386 |
Number of pages | 20 |
Journal | Future Microbiology |
Volume | 8 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2013 |
Externally published | Yes |
Keywords
- Chlamydia trachomatis
- NAAT
- organism load
- point-of-care
- screening
- self-collected specimen
- serovar
- sexually transmitted infection
- testing